Benson Kiniboro

Goroka, EHG, Papua New Guinea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Protective immunity to clinical malaria is modified by the genetic diversity of P. falciparum antigens.

Protective immunity to clinical malaria is modified by the genetic diversity of P. falciparum antigens.

Journal: The Journal of infection

Published: February 24, 2026

Correction: An antibody screen of a Plasmodium vivax antigen library identifies novel merozoite proteins associated with clinical protection.

Correction: An antibody screen of a Plasmodium vivax antigen library identifies novel merozoite proteins associated with clinical protection.

Journal: PLoS neglected tropical diseases

Published: May 22, 2025

Association of a Novel IgG3 Allele With Malaria in Children From the Sepik Region of Papua New Guinea.

Association of a Novel IgG3 Allele With Malaria in Children From the Sepik Region of Papua New Guinea.

Journal: The Journal of infectious diseases

Published: April 02, 2025

A longitudinal study of children identifies antibody Fc-mediated functions and antigen targets of immunity to Plasmodium vivax malaria.

A longitudinal study of children identifies antibody Fc-mediated functions and antigen targets of immunity to Plasmodium vivax malaria.

Journal: Immunity

Published: December 09, 2024

The probability of Plasmodium vivax acute illness following primary infection and relapse in Papua New Guinea.

The probability of Plasmodium vivax acute illness following primary infection and relapse in Papua New Guinea.

Journal: PLoS neglected tropical diseases

Published: January 09, 2024

Reticulocyte Binding Protein Homologue 5 is a target of balancing selection in the Plasmodium falciparum population of Papua New Guinea.

Reticulocyte Binding Protein Homologue 5 is a target of balancing selection in the Plasmodium falciparum population of Papua New Guinea.

Journal: Frontiers in parasitology

Published: September 08, 2023

Identification of novel Plasmodium vivax proteins associated with protection against clinical malaria.

Identification of novel Plasmodium vivax proteins associated with protection against clinical malaria.

Journal: Frontiers in cellular and infection microbiology

Published: October 21, 2022

Assessment of IgG3 as a serological exposure marker for Plasmodium vivax in areas with moderate-high malaria transmission intensity.

Assessment of IgG3 as a serological exposure marker for Plasmodium vivax in areas with moderate-high malaria transmission intensity.

Journal: Frontiers in cellular and infection microbiology

Published: May 23, 2022

Co-infection of the four major Plasmodium species: Effects on densities and gametocyte carriage.

Co-infection of the four major Plasmodium species: Effects on densities and gametocyte carriage.

Journal: PLoS neglected tropical diseases

Published: May 03, 2022

The epidemiology of Plasmodium falciparum and Plasmodium vivax in East Sepik Province, Papua New Guinea, pre- and post-implementation of national malaria control efforts.

The epidemiology of Plasmodium falciparum and Plasmodium vivax in East Sepik Province, Papua New Guinea, pre- and post-implementation of national malaria control efforts.

Journal: Malaria journal

Published: January 20, 2020

Differential impact of malaria control interventions on P. falciparum and P. vivax infections in young Papua New Guinean children.

Differential impact of malaria control interventions on P. falciparum and P. vivax infections in young Papua New Guinean children.

Journal: BMC medicine

Published: August 18, 2019

Protective Immunity against Severe Malaria in Children Is Associated with a Limited Repertoire of Antibodies to Conserved PfEMP1 Variants.

Protective Immunity against Severe Malaria in Children Is Associated with a Limited Repertoire of Antibodies to Conserved PfEMP1 Variants.

Journal: Cell host & microbe

Published: March 01, 2019

Showing 1-12 of 27

Last Updated: 09/26/2026